Current Neuro-Oncology

Volume 28 Number 20
20 July 2026

Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 20, 20 July

Shamsan GA, Liu CJ, Braman BC, Li R, Rathe SK, Sarver AL, Ghaderi N, McMahon M, Klank RL, Tschida BR, McFarren SJ, Rosato PC, Masopust D, Sarkaria JN, Clark HB, Rosenfeld S, Largaespada DA, Odde DJ.
Glioblastoma subtypes exhibit distinct migration mechanics and immune responses.
Cancer Res Commun. 2026 Jul 14. doi: 10.1158/2767-9764.CRC-25-0579. PMID: 42447444. ˍ

Yanchu L, Hongbin W, Xiaoli Y, Li Z, Jun W, Meiling R, Xiaoyan Y, Lei L, Feng W.
Pilot report of an anti-PD-1/VEGF bispecific antibody for treating recurrent H3K27M-mutant diffuse midline gliomas.
Cancer Immunol Immunother. 2026 Jul 14. doi: 10.1007/s00262-026-04434-8. PMID: 42446735. ˍ

Carranza O, Pant S, Schuler M, Witt O, Geoerger B, Loriot Y, Farouk Sait S, Arnold D, Dal Molin GZ, Lugowska I, Winter H, Baldini C, Corassa M, Thomas S, Crow L, Xia Y, Triantos S, Sweiti H, Reardon DA.
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.
JCO Precis Oncol. 2026 Jul 15;10(7):e2501094. doi: 10.1200/PO-25-01094. PMID: 42456086. Trial registration ID: NCT04083976. ˍ

Zhu C, Zeltser N, Oh J, Li CH, Boutros PC.
Sex differences in the cancer proteome.
BMJ Oncol. 2026 Jul 15;5(2):e001130. doi: 10.1136/bmjonc-2026-001130. PMID: 42466117. ˍ